Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Pfizer/Lilly Discontinue Tanezumab, The Likely End For A Class Dogged By Safety
26 Oct 2021
•
By
Jessica Merrill
Pfizer and Lilly closed the book on tanezumab • Source: Alamy
More from New Products
More from Scrip